Loading clinical trials...
Loading clinical trials...
Randomized Double-blinded Comparative Trial to Study the Add-on Activity of Combination Treatment of Nicotinamide on Progression Free Survival for EGFR Mutated Lung Cancer Terminal Stage Patients Being Treated With Gefitinib or Erlotinib
Conditions
Interventions
Nicotinamide
Locations
1
South Korea
Chonnam National University Hwasun Hospital
Hwasun, Chonnam, South Korea
Start Date
March 1, 2015
Primary Completion Date
March 1, 2020
Completion Date
June 1, 2020
Last Updated
January 27, 2020
NCT06487078
NCT06461338
NCT04738487
NCT04990479
NCT03950674
NCT03770299
Lead Sponsor
Il Yeong Park, Ph.D.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions